Estimating protein-ligand binding affinity using high-throughput screening by NMR.

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Structural Biology

Background:

• High-throughput screening (HTS) is crucial for modern drug discovery, relying on rapid protein activity assessments to rank chemical leads.
• Nuclear Magnetic Resonance (NMR) spectroscopy offers a method to validate drug discovery leads by monitoring protein-ligand interactions.
• Current NMR screening methods face limitations in throughput and sample requirements, hindering the measurement of binding affinities for large compound libraries.

Purpose of the Study:

• To develop a methodology for ranking ligand binding affinities using NMR screening.
• To overcome the limitations of current NMR techniques in quantifying binding affinities.
• To enable more comprehensive validation and optimization of drug discovery leads.

Main Methods:

• Utilized 1D (1)H NMR line-broadening experiments for ligand screening.
• Developed a novel methodology to estimate dissociation equilibrium constants (Kd) from NMR data.
• Applied the method to assess twelve ligands binding to human serum albumin (HSA).

Main Results:

• Successfully implemented a new NMR-based methodology to rank ligand binding affinities.
• Estimated dissociation equilibrium constants for twelve ligands with human serum albumin.
• Demonstrated good agreement between estimated and previously reported binding affinities.

Conclusions:

• The developed NMR methodology enables the ranking of ligand binding affinities, addressing a key limitation in current NMR screening.
• This approach enhances the utility of NMR in drug discovery by providing affinity estimates, not just binding detection.
• The method offers a practical means to optimize drug discovery processes through more accurate lead compound evaluation.